Log in to save to my catalogue

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile pr...

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile pr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e21e8d2652bd4aaba4120441ac9e5abb

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

About this item

Full title

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

Publisher

London: Nature Publishing Group UK

Journal title

npj vaccines, 2023-04, Vol.8 (1), p.52-52, Article 52

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The development of an effective and durable vaccine remains a central goal in the fight against malaria. Circumsporozoite protein (CSP) is the major surface protein of sporozoites and the target of the only licensed
Plasmodium falciparum
(Pf) malaria vaccine, RTS,S/AS01. However, vaccine efficacy is low and short-lived, highlighting the need...

Alternative Titles

Full title

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e21e8d2652bd4aaba4120441ac9e5abb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e21e8d2652bd4aaba4120441ac9e5abb

Other Identifiers

ISSN

2059-0105

E-ISSN

2059-0105

DOI

10.1038/s41541-023-00653-7

How to access this item